Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference80 articles.
1. Murren JR, DeVita VT . Another look at multidrug resistance Principles Practice Oncol Updates 1995 9: 1–12
2. Fisher GA, Sikic BI (eds) . Drug resistance in clinical oncology and hematology Hematol Oncol Clin N Am 1995 9: 239–382
3. Leith CP, Kopecky KJ, Godwin JE, McConnell T, Slovak M, Chen IM, Head DR, Appelbaum F, Willman CL . Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study Blood 1997 89: 3323–3329
4. Leith CP, Kopecky KJ, Chen IM, Eijdems L, Slovak ML, McConnell TS, Head DR, Weick J, Grever MR, Appelbaum FR, Willman CL . Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia. A Southwest Oncology Group study Blood 1999 94: 1086–1099
5. Samdani A, Vijapurkar U, Grimm MA, Spier CS, Grogan TM, Glinsmann-Gibson BJ, List AF . Cytogenetics and P-glycoprotein (PGP) are independent predictors of treatment outcome in acute myeloid leukemia (AML) Leukemia Res 1996 20: 175–180
Cited by
166 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献